Company Information
- Type:
- Company
- Country:
- United States of America
- Sector:
- Pharmaceuticals & Biotechnology
- Ownership:
- Privately Held
- Global Compact Status:
- Active
- Participant Since
- 17 May 2021 Letter of Commitment
- Next Communication on Progress (COP) due on:
- 31 July 2025
Engagements
Parent Company
| Country | Company Name |
|---|---|
| Belgium | UCB SA/NV |
Parent Communication On Progress
| Published On | Title | Level/Status |
|---|---|---|
| 01-Aug-2024 | 2024 Communication on Progress | Submitted |
| 03-Mar-2022 | UCB Integrated Annual report | Active |
| 29-Nov-2021 | Grace Letter | Not applicable |